Helix BioPharma (TSE:HBP) Stock Crosses Above Fifty Day Moving Average – What’s Next?

Helix BioPharma Corp. (TSE:HBP)’s share price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$2.08 and traded as high as C$2.10. Helix BioPharma shares last traded at C$2.05, with a volume of 607 shares traded.

Helix BioPharma Trading Up 4.1%

The company has a market capitalization of C$156.57 million, a P/E ratio of -29.29 and a beta of 0.32. The company has a debt-to-equity ratio of 2.19, a quick ratio of 1.04 and a current ratio of 0.23. The stock has a fifty day moving average of C$2.08 and a 200 day moving average of C$2.09.

Helix BioPharma Company Profile

Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today’s hardest-to-treat cancers. The Company’s pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today’s front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix’s next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery.